Latest News About Humulin R Insulin 100 Units, 10Ml Vial

I don’t have live, up-to-date access right now to pull the latest news directly, but here’s what’s broadly known about Humulin R 100 units/mL 10 mL vials and recent supply changes.

• Background: Humulin R is a short-acting human insulin produced by Eli Lilly. In several regions, Eli Lilly and other manufacturers have been discontinuing certain older vial presentations (including Humulin R 10 mL vials) in favor of alternative formats like prefilled pens or smaller cartridge presentations. This reflects a global trend toward newer delivery formats and consolidating product lines.[1][3][8]
• UK/Europe context: Medicine supply notifications have indicated that Humulin I, Humulin S, and Humulin M3 10 mL vials are being discontinued with stock forecasts showing end-of-life timelines in 2026, while alternative formats (such as pens or cartridges) are being recommended for continuity of care.[3][4][8]
• US context: DailyMed/FDA labeling for Humulin R 100 U/mL confirms the product existence, but there has historically been movement toward supply adjustments and alternate presentations; patients should rely on their healthcare provider to determine if replacement options (e.g., different insulin types or delivery formats) are warranted if a specific vial presentation is unavailable.[4][7]
• Practical impact for patients: If your local pharmacy or supplier marks Humulin R 10 mL vials as discontinued or out of stock, clinicians often transition patients to compatible alternatives such as Humulin R in a different presentation, or to a different regular/rapid-acting insulin with appropriate dosing adjustments. Always consult your prescriber before making changes to insulin type, dosing, or delivery method.[7][3][4]

Illustrative example

• Scenario: A patient has been using Humulin R 10 mL vials and learns the 10 mL presentation is discontinued. A clinician may switch them to Humulin R in a pen cartridge format with a compatible reusable pen, or transition to another rapid-acting insulin if clinically appropriate, ensuring similar glycemic control and monitoring for hypoglycemia during the switch.[3][4]

If you want, I can search for the very latest region-specific status (e.g., United States, UK, EU) and provide current availability, exact discontinuation dates, and recommended alternatives from official sources. Would you like me to look that up for Santa Clara, CA or your country/region? I can also help you prepare questions to ask your pharmacist or prescriber.

Sources:

• Discontinuation notices and stock timelines for Humulin 10 mL vials and related insulins in the UK and Europe.[8][3]
• General Humulin R labeling and product formats.[4][7]